ANTEOTECH LTD — Interim / Quarterly Report 2017

Jul 30, 2017

Rule 4.7B

Appendix 4C

Quarterly report for entities subject to Listing Rule 4.7B

introduced 31/03/00 Amended 30/09/01, 21/10/05, 17/12/10, 01/09/16

Name of entity

Anteo Diagnostics Limited

Consolidated statement of cash flows Current quarter ’000€ 1 Cash flows related to operating activities 4,530 1.2 Payments for (a) research and development (excluding staff costs relating to R&D) (162) (b) product manufacturing and operating costs (1,574) (c) advertising and marketing (421) (d) leased assets (17) (e) staff costs (1,543) (f) other working capital (1,146) 1.3 Dividends received - 1.4 Interest received 37 1.5 Interest and other costs of finance paid (265) 1.6 Income taxes paid - 1.7 Government grants and tax incentives 97 1.8 Other (provide details if material) - 1.9 Net cash from / (used in) operating activities (463) Cash flows related to investing activities 2.1 Payment to acquire: (a) property, plant and equipment (458) (b) businesses - (c) investments - (c) intellectual property - (e) other non-current assets - 2.2 Proceeds from disposal of: 75-070-028-625 ACN or ARBN 1.1 Receipts from customers and government grants 2

Quarter ended (“current quarter”) 30-Jun-17 Year to date (12 months) ’000€ 15,987 (596) (5,990) (780) (170) (6,224) (3,362) - 65 (1,349) (56) 1,870 - (605) (593) - - - -

==> picture [518 x 641] intentionally omitted <==

----- Start of picture text -----

- -
(a) property, plant and equipment
- -
(b) businesses
- -
(c) investments
- -
(c) intellectual property
(e) other non-current assets - -
2.3 Cash flow from loans to other entities - -
2.4 Dividends received - -
2.5 Other (provided details if material) - -
2.6 Net cash from / (used in) investing activities (458) (593)
3 Cash flows from financing activities
3.1 Proceeds from issues of shares 155 155
3.2 Proceeds from issue of convertible notes - 457
3.3 Proceeds from exercise of share options - -
3.4 Transaction costs related to issues of shares, convertible notes or
- -
options
3.5 Proceeds from borrowings 1,379 1,974
3.6 Repayment of borrowings (31) (2,316)
3.7 Transaction costs related to loans and borrowings - -
3.8 Dividends paid - -
3.9 Other (provide details if material) - -
3.10 Net cash from / (used in) financing activities 1,503 270
4 Net increase (decrease) in cash and cash equivalents for the period
4.1 Cash and cash equivalents at beginning of quarter/year to date 1,066 2,522
4.2 Net cash from / (used in) operative activities (item 1.9 above) (463) (605)
4.3 Net cash from / (used in) investing activities (item 2.6 above) (458) (593)
4.4 Net cash from / (used in) financing activities (item 3.10 above) 1,503 270
4.5 Effect of movement in exchange rate on cash held 83 137
4.6 Cash and cash equivalents at end of quarter 1,731 1,731
Reconciliation of cash at the end of the quarter (as shown in the Current Previous
consolidated statement of cash flows) to the related items in the accounts quarter quarter
5 is as follows. ’000 € ’000 €
5.1 Bank balances 1,650 985
5.2 Call deposits 81 81
5.3 Bank overdrafts - -
5.4 Other (provide details) - -
5.5 Cash and cash equivalents at end of quarter (should equal item 4.6
above) 1,731 1,066
----- End of picture text -----

6 Payments to directors of the entity and their associates	Current quarter ’000€

==> picture [518 x 733] intentionally omitted <==

----- Start of picture text -----

6.1 Aggregate amount of payments to these parties included in item 1.2 5
6.2 Aggregate amount of cash flow from loans to these parties included in
item 2.3
6.3 Include below any explaination necessary to understand the transactions included in
The Directors have deferred their directors fees while the group progresses
through the corporate activities it has underway.
7 Payments to related entities of the entity and their associates Current
quarter
’000 €
7.1 Aggregate amount of payments to these parties included in item 1.2
7.2 Aggregate amount of cash flow from loans to these parties included in
item 2.3
7.3 Include below any explaination necessary to understand the transactions included in
8 Financing facillities available Amount Amount used
available
add notes as necessary for an understanding of the position ’000 € ’000 €
8.1 Loan facilities -
8.2 Credit standby arrangements
8.3 Other (please specifiy)
8.4 Include below a description of each facility above. Inclluding the lender, interest rate and whether it is
9 Estimate cash outflow for next quarter ’000 €
9.1 Research and development (149)
9.2 Product manufacturing and operating costs (1,500)
9.3 Advertising and marketing (100)
9.4 Leased assets (45)
9.5 Staff costs (1,525)
9.6 Administration and corporate costs (250)
9.7 Other (provide details if material) (600)
9.8 Total estimated cash outflows (4,169)
Acquisitions and disposals of business entities
10 Acquisition and disposals of business entities (items 2.1 (b) and Acquisitions Disposals
2.2(b) above)
10.1 Name of entity
10.2 Place of incorporation or registration
10.3 Consideration for acquisition or disposal
10.4 Total net assets
10.5 Nature of business
----- End of picture text -----

Compliance statement

1 This statement has been prepared in accordance with accounting standards and polcies

• 2 This statement gives a true and fair view of the matters disclosed.

Print name: Peter Harding-Smith Date: 31-Jul-17 Company Secretary

Notes

• 1 The quarterly report provides a basis for informing the market how the entity’s activities

• 2 If this quarterly report has been prepared in accordance with Australia Accounting Standard, 3 Dividends received may be classified either as cash flows from operating activities or cash